NPS PHARMACEUTICALS INC
NPSP
NPSP was delisted on the 20th of February, 2015.
182 hedge funds and large institutions have $2.89B invested in NPS PHARMACEUTICALS INC in 2013 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 65 increasing their positions, 63 reducing their positions, and 12 closing their positions.
242% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 12
116% more capital invested
Capital invested by funds: $1.34B → $2.89B (+$1.55B)
100% more funds holding in top 10
Funds holding in top 10: 5 → 10 (+5)
17% more funds holding
Funds holding: 155 → 182 (+27)
3% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 63
6% less call options, than puts
Call options by funds: $21.4M | Put options by funds: $22.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$95.2M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$23.8M |
| 3 |
RIM
Rainier Investment Management
Seattle,
Washington
|
+$20.6M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$10.9M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$9.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$49.2M |
| 2 |
BC
Broadfin Capital
New York
|
-$28.6M |
| 3 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$17.5M |
| 4 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
-$12.7M |
| 5 |
RIM
RS Investment Management
San Francisco,
California
|
-$12.2M |
NPSP Hedge Fund Activity: Q3 2013 in Review
182 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q3 2013, worth a combined $2.89B — up 116% from $1.34B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new NPSP positions and 12 closed out — a net gain of 29 holders — while 65 added to existing stakes and 63 trimmed.
The largest buyer was Janus Henderson Investors US, adding an estimated $95.2M. The largest seller was Wellington Management Group, cutting an estimated $49.2M.
- 182 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q3 2013, up from 155 in Q2 2013.
- Funds reported $2.89B of NPS PHARMACEUTICALS INC stock for Q3 2013, up 116% quarter-over-quarter.
- 41 funds opened new NPS PHARMACEUTICALS INC positions in Q3 2013 and 12 closed out, a net change of +29 holders.
- The largest NPS PHARMACEUTICALS INC buyer in Q3 2013 was Janus Henderson Investors US, an estimated $95.2M added.
- The largest NPS PHARMACEUTICALS INC seller in Q3 2013 was Wellington Management Group, an estimated $49.2M sold.
Based on aggregated 13F filings for Q3 2013.